NORWOOD, Mass., Feb. 13, 2017 -- Xcerra Corporation (NASDAQ:XCRA), today announced the Company will release financial results for its second fiscal quarter ended January 31, 2017, on Tuesday, February 21st, before the market opens. A conference call will follow at 10:00 a.m. EST to discuss the Company’s second quarter fiscal 2017 financial results and provide third quarter fiscal 2017 guidance.
The conference call may be accessed via telephone by dialing 877.853.5334. The call will be simulcast via the Xcerra web site http://xcerra.com/investors/events-presentations/. Audio replays of the call can be heard through February 24, 2017, via telephone, by dialing 855.859.2056; conference ID number 66523985. A replay of the webcast can be accessed by visiting our web site 90 minutes following the conference call at http://xcerra.com/investors/events-presentations/.
About Xcerra
Xcerra Corporation is comprised of four businesses in the semiconductor and electronics manufacturing test markets: atg-Luther & Maelzer, Everett Charles Technologies, LTX-Credence and Multitest. The combination of these businesses creates a company with a broad spectrum of semiconductor and PCB test expertise that drives innovative new products and services, and the ability to deliver to customers fully integrated semiconductor test cell solutions. The Company addresses the broad, divergent requirements of the mobility, industrial, automotive and consumer end markets, offering a comprehensive portfolio of solutions and technologies, and a global network of strategically deployed applications and support resources. Additional information can be found at www.xcerra.com or at each product group’s website; www.atg-lm.com, www.ectinfo.com, www.ltxc.com and www.multitest.com
Xcerra is a trademark of Xcerra Corporation.
All other trademarks are the property of their respective owners.
Investor Contact: Richard Yerganian, Vice President, Investor Relations Xcerra Corporation Tel. 781.467.5063 Email [email protected]


Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
BP Nears $10 Billion Castrol Stake Sale to Stonepeak 



